Dexcom announces novel wearable for managing Type 2 diabetes – without insulin – TechToday
Dexcom, a maker of continuous glucose monitors, is developing a Type 2 diabetes monitor for those who don’t need insulin that has a 15-day sensor and a cash-pay option for patients not covered by Medicare and health insurers that want daily decision support.
With the number of diabetes-affected Americans numbering more than 37 million, according to the U.S. Centers for Disease Control, healthcare technology developers and researchers seek to enhance the prevention, early detection, management and care of diabetes.
“There are three key decisions that somebody with Type 2 diabetes who is not taking insulin makes,” said Dexcom Chief Executive Kevin Sayer, according to a report last week in the San Diego Union-Tribune.
“Those decisions are exercise, food and meds.”
Sayers reportedly told attendees at an American Diabetes Conference in San Diego that the company’s new sensor – which is about a year or more from market launch – would help the millions of patients managing Type 2 diabetes without insulin, and that it would help millions of prediabetic patients learn how their daily habits affect their conditions.
While 10% of adults worldwide have been diagnosed with Type 2 diabetes mellitus, it’s a smaller percentage that requires multiple medications to control blood glucose levels and avoid serious complications, according to researchers at the University of Utah Health, Regenstrief Institute and Hitachi who are looking to the use of artificial intelligence to analyze electronic health record data for T2DM characteristics.
“With this system, they can look at their meal planning. They can look at their exercise. They can look at whatever meds they take – be it diabetes meds or meds for other conditions,” Sayers explained about the new wearable medical device Dexcom is developing and the U.S. government is reviewing.
He said in general, wearable glucose monitors must show how they can help reduce costs throughout the healthcare system.
“One-quarter of the dollars spent in the U.S. on healthcare are spent on diabetes,” he said.
“The only way to change these trends is to give people information that can make their health better.”
Dexcom also announced on Tuesday that its G7 CGM, which has a predictive urgent low-alert feature in addition to real-time alerts for those who use insulin to manage their diabetic conditions, received market approval from Health Canada.
The CGM device received U.S. market approval in December. In January, Sayers told MobiHealthNews that with the emergence of the new G7 platform, Dexcom CGMs have become “interoperable and connectable” with greater cybersecurity.
Andrea Fox is senior editor of Healthcare IT News.
Email: afox@himss.org
Healthcare IT News is a HIMSS Media publication.
Post Publications || Join us on Whatsapp || Post Disclaimer
SEND A STORY: Do you have a story for us or need a promotion/advertisement? Submit them via our email admin@edulearnweb or Ghanaeducation.org
TELEGRAM PAGE >>> [JOIN]
DOWNLOAD OUR EDUCATION NEWS APP - MOBILE APP
JOIN OUR EDUCATION NEW GROUPS (WHATSAPP)
Join one of our Whatsapp/Telegram Groups for current Ghana Education Service News Updates:
JOIN ONLY ONE... THANKS
TELEGRAM PAGE >>> [JOIN]
Group 1 >>New Group> [JOIN]
Group 2 >>New Group> [JOIN]
TELEGRAM PAGE >>> [JOIN]
Only websites that give us a URL backlink can repost our content on their sites.
The information contained in this post is for general information purposes only. The information is provided by edulearnweb.com and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the post for any purpose.
||About Us|| Contact Us